Phase 2 Study of 4-Aminopyridine for the Treatment of Episodic Ataxia Type 2
Phase of Trial: Phase II
Latest Information Update: 07 Apr 2014
At a glance
- Drugs Fampridine (Primary)
- Indications Ataxia
- Focus Pharmacodynamics
- Acronyms 4AP in EA2
- 07 Feb 2014 Planned end date changed from 1 Apr 2014 to 1 Apr 2016 as reported by ClinicalTrials.gov record.
- 07 Feb 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 12 Mar 2012 New trial record